TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 94 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,743,791 | -58.3% | 5,118,050 | -27.4% | 0.00% | -60.0% |
| Q2 2023 | $61,690,528 | -65.9% | 7,050,346 | -53.9% | 0.01% | -37.5% |
| Q1 2023 | $180,980,510 | +140.9% | 15,285,516 | +107.2% | 0.01% | +14.3% |
| Q4 2022 | $75,114,565 | +12440.0% | 7,378,641 | +7159.7% | 0.01% | – |
| Q3 2022 | $599,000 | +137.7% | 101,639 | -0.0% | 0.00% | – |
| Q2 2022 | $252,000 | -96.3% | 101,675 | -95.6% | 0.00% | -100.0% |
| Q1 2022 | $6,895,000 | -65.2% | 2,321,458 | -17.1% | 0.00% | 0.0% |
| Q4 2021 | $19,803,000 | -35.2% | 2,800,985 | -4.5% | 0.00% | -50.0% |
| Q3 2021 | $30,564,000 | -17.5% | 2,933,162 | -3.0% | 0.00% | -33.3% |
| Q2 2021 | $37,057,000 | -41.7% | 3,022,557 | +4.7% | 0.00% | -40.0% |
| Q1 2021 | $63,530,000 | – | 2,887,738 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |